330 related articles for article (PubMed ID: 31492775)
1. Strength training as a supplemental therapy for androgen deficiency of the aging male (ADAM): study protocol for a three-arm clinical trial.
Kralik M; Cvecka J; Buzgo G; Putala M; Ukropcova B; Ukropec J; Killinger Z; Payer J; Kollarik B; Bujdak P; Raastad T; Sedliak M
BMJ Open; 2019 Sep; 9(9):e025991. PubMed ID: 31492775
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.
Thorsen L; Nilsen TS; Raastad T; Courneya KS; Skovlund E; Fosså SD
BMC Cancer; 2012 Mar; 12():123. PubMed ID: 22458865
[TBL] [Abstract][Full Text] [Related]
3. Testosterone therapy preserves muscle strength and power in aging men with type 2 diabetes-a randomized controlled trial.
Magnussen LV; Hvid LG; Hermann AP; Hougaard DM; Gram B; Caserotti P; Andersen MS
Andrology; 2017 Sep; 5(5):946-953. PubMed ID: 28914503
[TBL] [Abstract][Full Text] [Related]
4. Effects of Testosterone and Evoked Resistance Exercise after Spinal Cord Injury (TEREX-SCI): study protocol for a randomised controlled trial.
Gorgey AS; Khalil RE; Gill R; O'Brien LC; Lavis T; Castillo T; Cifu DX; Savas J; Khan R; Cardozo C; Lesnefsky EJ; Gater DR; Adler RA
BMJ Open; 2017 Apr; 7(4):e014125. PubMed ID: 28377392
[TBL] [Abstract][Full Text] [Related]
5. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
6. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.
Wang C; Swerdloff RS; Iranmanesh A; Dobs A; Snyder PJ; Cunningham G; Matsumoto AM; Weber T; Berman N;
J Clin Endocrinol Metab; 2000 Aug; 85(8):2839-53. PubMed ID: 10946892
[TBL] [Abstract][Full Text] [Related]
7. Examining the effects of creatine supplementation in augmenting adaptations to resistance training in patients with prostate cancer undergoing androgen deprivation therapy: a randomised, double-blind, placebo-controlled trial.
Fairman CM; Kendall KL; Newton RU; Hart NH; Taaffe DR; Chee R; Tang CI; Galvão DA
BMJ Open; 2019 Sep; 9(9):e030080. PubMed ID: 31542747
[TBL] [Abstract][Full Text] [Related]
8. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS
J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818
[TBL] [Abstract][Full Text] [Related]
9. Mechanical muscle function and lean body mass during supervised strength training and testosterone therapy in aging men with low-normal testosterone levels.
Kvorning T; Christensen LL; Madsen K; Nielsen JL; Gejl KD; Brixen K; Andersen M
J Am Geriatr Soc; 2013 Jun; 61(6):957-962. PubMed ID: 23730808
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria, glycogen, and lipid droplets in skeletal muscle during testosterone treatment and strength training: a randomized, double-blinded, placebo-controlled trial.
Jensen RC; Christensen LL; Nielsen J; Schrøder HD; Kvorning T; Gejl K; Højlund K; Glintborg D; Andersen M
Andrology; 2018 Jul; 6(4):547-555. PubMed ID: 29656500
[TBL] [Abstract][Full Text] [Related]
11. Androgen replacement therapy to reverse and/or prevent age-associated sarcopenia in men.
Tenover JS
Baillieres Clin Endocrinol Metab; 1998 Oct; 12(3):419-25. PubMed ID: 10332563
[TBL] [Abstract][Full Text] [Related]
12. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
[TBL] [Abstract][Full Text] [Related]
13. Testosterone Replacement Therapy Added to Intensive Lifestyle Intervention in Older Men With Obesity and Hypogonadism.
Barnouin Y; Armamento-Villareal R; Celli A; Jiang B; Paudyal A; Nambi V; Bryant MS; Marcelli M; Garcia JM; Qualls C; Villareal DT
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1096-e1110. PubMed ID: 33351921
[TBL] [Abstract][Full Text] [Related]
14. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.
Page ST; Amory JK; Bowman FD; Anawalt BD; Matsumoto AM; Bremner WJ; Tenover JL
J Clin Endocrinol Metab; 2005 Mar; 90(3):1502-10. PubMed ID: 15572415
[TBL] [Abstract][Full Text] [Related]
15. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
Strawford A; Barbieri T; Van Loan M; Parks E; Catlin D; Barton N; Neese R; Christiansen M; King J; Hellerstein MK
JAMA; 1999 Apr; 281(14):1282-90. PubMed ID: 10208143
[TBL] [Abstract][Full Text] [Related]
16. Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects.
Colleluori G; Chen R; Turin CG; Vigevano F; Qualls C; Johnson B; Mediwala S; Villareal DT; Armamento-Villareal R
Front Endocrinol (Lausanne); 2020; 11():277. PubMed ID: 32499757
[No Abstract] [Full Text] [Related]
17. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.
Emmelot-Vonk MH; Verhaar HJ; Nakhai Pour HR; Aleman A; Lock TM; Bosch JL; Grobbee DE; van der Schouw YT
JAMA; 2008 Jan; 299(1):39-52. PubMed ID: 18167405
[TBL] [Abstract][Full Text] [Related]
18. Effect of Exercise Training and Testosterone Replacement on Skeletal Muscle Wasting in Patients With Heart Failure With Testosterone Deficiency.
Dos Santos MR; Sayegh AL; Bacurau AV; Arap MA; Brum PC; Pereira RM; Takayama L; Barretto AC; Negrão CE; Alves MJ
Mayo Clin Proc; 2016 May; 91(5):575-86. PubMed ID: 27040087
[TBL] [Abstract][Full Text] [Related]
19. LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report.
Cardaci TD; Machek SB; Wilburn DT; Heileson JL; Harris DR; Cintineo HP; Willoughby DS
Exp Physiol; 2022 Dec; 107(12):1467-1476. PubMed ID: 36303408
[TBL] [Abstract][Full Text] [Related]
20. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
